Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Neutropenia while receiving anti-tumour necrosis factor treatment for rheumatoid arthritis.

Authors: D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J W J Bijlsma; M Dougados; P Emery; E C Keystone; L Klareskog; P J Mease
Journal: Ann Rheum Dis Date: 2005-11 Impact factor: 19.103

6. Aplastic anemia following administration of a tumor necrosis factor-alpha inhibitor.

Authors: John Kuruvilla; Heather A Leitch; Linda M Vickars; Paul F Galbraith; Charles H Li; Saad Al-Saab; Sheldon C Naiman
Journal: Eur J Haematol Date: 2003-11 Impact factor: 2.997

7. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.

Authors: R N Maini; F C Breedveld; J R Kalden; J S Smolen; D Davis; J D Macfarlane; C Antoni; B Leeb; M J Elliott; J N Woody; T F Schaible; M Feldmann
Journal: Arthritis Rheum Date: 1998-09

7 in total

13 in total

1. Re-challenge with etanercept in patients with etanercept-induced neutropenia.

Authors: Muhammad Haroon; Mary Daly; Sinead Harney
Journal: Clin Rheumatol Date: 2011-08-05 Impact factor: 2.980

Review 2. Neutropenia in the Elderly: A Rheumatology Perspective.

Authors: Su-Ann Yeoh; Christine Fox; Richard Hull
Journal: Drugs Aging Date: 2016-08 Impact factor: 3.923

Review 3. Tocilizumab-induced neutropenia in rheumatoid arthritis patients with previous history of neutropenia: case series and review of literature.

Authors: O Shovman; Y Shoenfeld; P Langevitz
Journal: Immunol Res Date: 2015-02 Impact factor: 2.829

Review 4. Should anti-TNF therapy be discontinued in rheumatoid arthritis patients undergoing elective orthopaedic surgery? A systematic review of the evidence.

Authors: Leslie Goh; Teresa Jewell; Catherine Laversuch; Ash Samanta
Journal: Rheumatol Int Date: 2011-07-29 Impact factor: 2.631

Neutropenia while receiving anti-tumour necrosis factor treatment for rheumatoid arthritis.

1. Severe neutropenia and thrombocytopenia associated with infliximab.

2. Update on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001).

Review 3. Etanercept: a review of its use in rheumatoid arthritis.

Review 4. Infliximab: a review of its use in the management of rheumatoid arthritis.

Review 5. Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005.

6. Aplastic anemia following administration of a tumor necrosis factor-alpha inhibitor.

7. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.

1. Re-challenge with etanercept in patients with etanercept-induced neutropenia.

Review 2. Neutropenia in the Elderly: A Rheumatology Perspective.

Review 3. Tocilizumab-induced neutropenia in rheumatoid arthritis patients with previous history of neutropenia: case series and review of literature.

Review 4. Should anti-TNF therapy be discontinued in rheumatoid arthritis patients undergoing elective orthopaedic surgery? A systematic review of the evidence.

Review 5. Drug-Induced Neutropenia During Treatment of Non-Neoplastic Dermatologic Diseases: A Review.

6. Regulation of hematopoietic stem cell activity by inflammation.

7. Adalimumab Induced or Provoked MS in Patient with Autoimmune Uveitis: A Case Report and Review of the Literature.

8. Neutropaenia in early rheumatoid arthritis: frequency, predicting factors, natural history and outcome.

Review 9. State of Art of Idiosyncratic Drug-Induced Neutropenia or Agranulocytosis, with a Focus on Biotherapies.

Review 10. Etanercept-associated transient bone marrow aplasia: a review of the literature and pathogenetic mechanisms.